All news
-
Prensa
- Galería de imágenes
- Librería de vídeos
- Safer chemicals podcast
-
Temas científicos candentes
- Prevención del cáncer
- Sustancias químicas sensibilizantes de la piel
- Sustancias perfluoroalquiladas y polifluoroalquiladas (PFAS)
- Microplásticos
- El granulado y las cortezas de caucho en los campos deportivos
- Tintas para tatuajes y maquillaje permanente
- Glifosato
- Alteradores endocrinos
- Bisfenoles
- Estrategia de sostenibilidad para las sustancias químicas
- Los ensayos con animales en el ámbito de REACH
- Ftalatos
- Biocides
- Plomo
- Research to enhance protection of our health and environment
- Corporate and visual Identity
- ECHA Articles
All news
Member States to evaluate 96 substances in 2019-2021
An addition was made to the draft CoRAP (24 October 2018): four substances were added to it. The plan for 2019-2021 now contains altogether 100 substances for evaluation in 2019, 2020 and 2021. Of these substances, 31 are currently planned for evaluation in 2019. Also one substance’s year of evaluation was changed and one editorial mistake corrected.
ECHA/NR/18/53
ECHA proposes 96 substances for evaluation by Member States under the Community rolling action plan (CoRAP) for 2019-2021. If you have registered any of these substances, you should coordinate actions with your co-registrants and contact the evaluating authority.
Helsinki, 10 October 2018 – 28 substances are planned to be evaluated in 2019, while 43 are currently listed for evaluation in 2020 and 25 for 2021. Registrants of a listed substance should start coordinating their actions and contact the evaluating Member State authority. Downstream users of a listed substance should review the information they have available and share it with the registrants.
In particular, it is important that the use and exposure scenarios as well as the exposure estimations are up to date and clearly documented within the registrants’ chemical safety reports. For the 28 substances planned to be evaluated in 2019, the relevant dossier updates should be made before March 2019.
The draft plan includes the non-confidential substance names, the CAS and EC numbers, the tentative year of evaluation, the contact details of the proposed evaluating Member State, and an indication of the initial area of concern. This year, the groups of structurally similar substances that could potentially be evaluated together are also marked in the plan.
The draft plan has been prepared together with the Member States, taking into account risk-based criteria for selecting the substances. At this draft stage, some changes to the plan are still possible. The final updated plan will be adopted in March 2019.
Registrants will soon be able to get an overview of substance-specific activities (including substance evaluation) using the updated public activities coordination tool (PACT). It offers companies one entry point to information about substances that are on an authority's radar and which are potentially going for regulatory risk management.
Next steps
ECHA’s Member State Committee will discuss the draft CoRAP this week and will prepare an opinion on the draft plan in February 2019. Based on the opinion, ECHA will adopt and publish the CoRAP update for 2019-2021 in March 2019. From the date of publication onwards, the Member States have one year to prepare a draft decision requesting further information from the respective registrants to clarify potential concerns identified during evaluation.
- Update: Member States to evaluate 100 substances in 2019-2021 (news release ECHA/NR/18/60 from 24 October 2018)
- Draft CoRAP 2019–2021 (updated on 22 October 2018) [PDF][EN]
- Substance evaluation
- Registrant's guide - how to act in substance evaluation [PDF][EN]
- Interaction between the evaluating Member State and the registrants under substance evaluation – Recommendations [PDF][EN]
- Public activities coordination tool (PACT)